GTBP
GT Biopharma Inc
Price:  
2.24 
USD
Volume:  
531,743.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GTBP Intrinsic Value

-1,185.23 %
Upside

What is the intrinsic value of GTBP?

As of 2025-05-20, the Intrinsic Value of GT Biopharma Inc (GTBP) is -24.31 USD. This GTBP valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.24 USD, the upside of GT Biopharma Inc is -1,185.23%.

Is GTBP undervalued or overvalued?

Based on its market price of 2.24 USD and our intrinsic valuation, GT Biopharma Inc (GTBP) is overvalued by 1,185.23%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

2.24 USD
Stock Price
-24.31 USD
Intrinsic Value
Intrinsic Value Details

GTBP Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -24.31 - -24.31 -24.31 -1,185.23%
P/E (115.32) - (225.20) (132.73) -6025.3%
DDM - Stable (32.83) - (97.40) (65.11) -3006.9%
DDM - Multi (28.91) - (69.92) (41.28) -1943.0%

GTBP Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 5.69
Beta 0.79
Outstanding shares (mil) 2.54
Enterprise Value (mil) 1.74
Market risk premium 4.60%
Cost of Equity 11.43%
Cost of Debt 5.00%
WACC 7.55%